Abstract

Natural killer (NK) cells use the activating receptor NKp30 as a microbial pattern-recognition receptor to recognize, activate cytolytic pathways, and directly kill the fungi Cryptococcus neoformans and Candida albicans. However, the fungal pathogen-associated molecular pattern (PAMP) that triggers NKp30-mediated killing remains to be identified. Here we show that β-1,3-glucan, a component of the fungal cell wall, binds to NKp30. We further demonstrate that β-1,3-glucan stimulates granule convergence and polarization, as shown by live cell imaging. Through Src Family Kinase signaling, β-1,3-glucan increases expression and clustering of NKp30 at the microbial and NK cell synapse to induce perforin release for fungal cytotoxicity. Rather than blocking the interaction between fungi and NK cells, soluble β-1,3-glucan enhances fungal killing and restores defective cryptococcal killing by NK cells from HIV-positive individuals, implicating β-1,3-glucan to be both an activating ligand and a soluble PAMP that shapes NK cell host immunity.

Details

Title
Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida
Author
Li, Shu Shun 1 ; Ogbomo, Henry 1 ; Mansour, Michael K 2 ; Xiang, Richard F 1 ; Szabo, Lian 3 ; Munro, Fay 4 ; Mukherjee, Priyanka 4 ; Mariuzza, Roy A 5 ; Amrein, Matthias 4 ; Vyas, Jatin M 2   VIAFID ORCID Logo  ; Robbins, Stephen M 6 ; Mody, Christopher H 7   VIAFID ORCID Logo 

 Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada; The Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Canada 
 Department of Medicine Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA 
 Department of Medicine, University of Calgary, Calgary, Canada 
 Department of Cell Biology and Anatomy, University of Calgary, Calgary, Canada 
 Department of Cell Biology & Molecular Genetics, University of Maryland, College Park, MD, USA 
 Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada; Southern Alberta Cancer Research Institute, University of Calgary, Calgary, Canada 
 Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada; The Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Canada; Department of Medicine, University of Calgary, Calgary, Canada 
Pages
1-13
Publication year
2018
Publication date
Feb 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2007093373
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.